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Abstract Aging has been defined as the changes that occur in
living organisms with the passage of time that lead to func-
tional impairment and ultimately to death. Free radical-
induced oxidative damage has long been thought to be the
most important consequence of the aging process. In the
present study, an attempt has been made to study the salubri-
ous effects of dietary supplementation of chitosan on
glutathione-dependent antioxidant defense system in young
and aged rats. The dietary supplementation of chitosan signif-
icantly reduced the age-associated dyslipidemic abnormalities
noted in the levels of total cholesterol, HDL-cholesterol, and
LDL-cholesterol in plasma and heart tissue. Its administration
significantly (P<0.05) attenuated the oxidative stress in the
heart tissue of aged rats through the counteraction of free
radical formation by maintaining the enzymatic [glutathione
peroxidase (GPx) and glutathione reductase (GR)] and non-
enzymatic [reduced glutathione (GSH)] status at levels com-
parable to that of normal young rats. Our results conclude that
dietary intake of chitosan restores the depleted myocardial
antioxidant status and suggest that it could be an effective
therapeutic agent in treatment of age-associated disorders
where hypercholesterolemia and oxidative stress are the major
causative factors.
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Introduction
Aging, a multifactorial process of enormous complexity, is
characterized by impairment of physiochemical and biolog-
ical aspects of cellular functions (Harman 1992). Oxidative
stress, an unavoidable consequence in the metabolism of
oxygen in aerobic cells, is a major factor in the aging
process and, in the course of many chronic diseases, asso-
ciated with aging (Mattson 2002). Many predisposing con-
ditions which increase in prevalence during aging, such as
obesity, insulin resistance, inflammation, changes in the
activity of the hypothalamus–hypophysis suprarenal axis,
stress, and hypertension, contribute to increase prevalence
of cardiovascular diseases (Veronica and Esther 2012).
Lipid infiltration in the myocardium is the foremost disorder
encountered in the development of the aging process
(Johannsen and Ravussin 2010). Aging is frequently accom-
panied by several pathological conditions and some associ-
ated phenomena such as increased lipid peroxidation,
generation of free radicals, and increased peroxidation of
nitric oxide (NO) to its toxic species, resulting from oxida-
tive stress which significantly alters the incidence of cardio-
vascular diseases (Guarner et al. 2005). Alteration in
glutathione-dependent antioxidant system is expected to
exert a significant impact on physiological and metabolic
functions of cellular membranes. Enhanced lipid peroxida-
tion and deterioration of membrane structure has been well
established during the aging process (Yu 2005). Preventing
and treating cardiovascular diseases would be useful in
promoting normal aging. The identification of natural mol-
ecule with antioxidant, antilipidemic, and membrane-
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stabilizing properties is, therefore, one strategy to facilitate
healthy aging.
Chitosan is one of the most abundant naturally occurring
polysaccharides present in shellfish, clams, krill, oysters,
squid, fungi, and insects (Cardenas et al. 2001). It is a
polymer of α-(1-4)-D-glucosamine (Fig. 1), and it is chem-
ically similar to that of the plant fiber, cellulose. It has been
reported to possess antilipidemic (Santhosh et al. 2006),
antioxidant (Xie et al. 2001), and membrane-stabilizing
properties (Filipovic-Grcic et al. 2001). Previously,
Anandan et al. (2004) observed the antiulcerogenic potential
of chitosan against HCl–ethanol-induced peptic ulcer in rats.
The free radical quenching property of this marine polysac-
charide has also been studied in detail (Xing et al. 2005).
Reports by Filipovic-Grcic et al. (2001) indicated the
membrane-stabilizing property of chitosan. It has profound
applications in the fields of clarification and purification,
chromatography, paper and textiles, photography, food and
nutrition, agriculture, pharmaceutical and medical, cosmet-
ics, biodegradable membranes, and biotechnology
(Santhosh et al. 2006). Though the beneficial effects of
chitosan have been extensively studied, the antiaging effect
of chitosan has not yet been explored.
In the present study, an attempt has been made to assess
the salubrious effect of dietary chitosan intake on myocar-
dial lipid peroxidation and glutathione-dependent antioxi-
dant status in young and aged rats by virtue of its
antioxidant and hypolipidemic properties.
Experimental
Drugs and chemicals
Reduced glutathione, tetraethoxypropane, and 2-thiobarbituric
acid were procured from M/s Sigma Chemical Company, St.
Louis, MO, USA. All other chemicals used were of analytical
grade. Chitosan (Mw, 750,000 Da; viscosity, 8 cP; deacetyla-
tion rate, 85–87 %; purity, 98.6 %) used in the experiment was
a kind gift from Dr. T. K. Thankkappan, Principal Scientist,
Central Institute of Fisheries Technology, Cochin, India.
Animals
Male Wistar strain albino rats, weighing 120–150 g [18
young rats of 2–3 months old (mean age, 79.2±6.53 days)]
and 350–400 g [18 aged rats of 20–25 months old (mean age,
712±51.6 days)], were selected for the study. The animals
were housed individually in polypropylene cages under hy-
gienic and standard environmental conditions (28±2 °C;
humidity, 60–70 %; 12 h light/dark cycle). The animals were
allowed a standard diet (M/s Sai Foods, Bangalore, India;
Table 1) and water ad libitum. The experiment was carried
out according to guidelines of the Committee for the Purpose
of Control and Supervision of Experiments on Animals, New
Delhi, India, and approved by the Institutional Animal Ethics
Committee of the Central Institute of Fisheries Technology,
Cochin, India.
Experimental protocol
Seven days after acclimatization, the animals were divided
into two major groups: Group I consisted of 18 normal young
rats and Group II consisted of 18 normal aged rats. Each group
was further subdivided into three groups (six rats each): one
control group (Group Ia and Group IIa) and two experimental
groups based on the duration of supplementation of chitosan
at 2 % level along with feed 30 days (Group Ib and Group IIb)
and 60 days (Group Ic and Group IIc).
At the end of the experimental period, the animals were
sacrificed, and the blood was collected in a heparinized tube
for the separation of plasma. The heart tissue was excised
immediately and homogenized in ice-cold 0.1-M Tris–HCl
buffer in a Potter–Elvehjem homogenizer. The homogenate
was used for the estimation of lipid peroxides (LPO;
Ohkawa et al. 1979), reduced glutathione (GSH; Ellman
1959), glutathione reductase (GR; Stall et al. 1969), and
glutathione peroxidase (GPX; Paglia and Valentine 1967).
Fig. 1 Structure of chitosan
Table 1 Composition of standard diet
S. No. Ingredients Composition (g/100 g diet)
1 Carbohydrate (nitrogen free) 56.2
2 Crude protein 22.0
3 Ash 7.5
4 Crude oil 4.2
5 Crude fiber 3.0
6 Glucose 2.5
7 Vitamins 1.8
8 Sand silica 1.4
9 Calcium 0.8
10 Phosphorus 0.6
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High-density lipoprotein-cholesterol (HDL-cholesterol) in
plasma was determined by the method of Izzo et al.
(1981), and low-density lipoprotein-cholesterol (LDL-cho-
lesterol) was estimated according to the calculation of
Friedwald et al. (1972). The total cholesterol was estimated
by the method of Allain et al. (1974) after extracting total
lipids according to the method of Folch et al. (1957).
Statistical analysis
Results are expressed as mean±SD. Multiple comparisons of
the significant ANOVAwere performed by Duncan's multiple
range comparison test. A P value<0.05 was considered as
statistically significant. All data were analyzed with the aid
of statistical package program SPSS 12.0 for Windows.
Results and discussion
Significant (P<0.05) variation was observed in the body
weight (grams) of young (initial, 129±9.05; final, 249±
18.3) and aged (initial, 382±27.2; final, 336±23.1) chitosan-
supplemented groups of rats. The significant (P<0.05) loss
observed in the body weight of chitosan-supplemented aged
animals might be related to the fibrous nature of chitosan.
Interestingly, the total food intake (grams per 60 days) of aged
chitosan-supplemented rats (904±78.4) was comparable to
that of young rats (745±59.5). Level of total cholesterol was
significantly (P<0.05) higher in plasma and heart tissue of
Group IIa aged rats as compared to Group Ia young control
rats, indicating the development of mild age-associated hy-
percholesterolemic condition (Tables 2 and 3). The level of
LDL-cholesterol was slightly (P<0.05) higher in Group IIa
aged rats, whereas HDL-cholesterol levels were significantly
lower compared to Group Ia young animals (Table 2). This
aspect might be due to the augmented mobilization of LDL-
cholesterol from the blood into the cell membranes, resulting
in abnormal cholesterol deposition in the myocardium. In the
present study, the dietary supplementation with chitosan sig-
nificantly reduced the total cholesterol level in plasma and
myocardial tissue of Group IIc aged rats as compared to
Group IIa rats. It also kept the levels of LDL-cholesterol and
HDL-cholesterol in plasma comparable to that of Group Ic
rats. The present observations concurs with an earlier reported
study (Baker et al. 2009), which showed that the positively
charged amino groups of chitosan possess the ability to bind
negatively charged molecules such as lipids and bile acids,
inducing a greater fractional excretion in the feces. Also,
Table 2 Effect of dietary chitosan supplementation on total cholesterol, HDL-cholesterol, and LDL-cholesterol in plasma of young and aged rats













Total cholesterol 79.9±5.36 a,b 76.2±4.98 a,b 73.1±5.07 a 98.4±9.12 c 91.7±8.56 c 87.3±8.21 b,c
HDL-cholesterol 42.2±3.11 a,b,c 44.9±3.48 b,c 47.5±3.29 c 33.2±2.68 d 36.4±2.56 a 39.7±3.74 a,b
LDL-cholesterol 24.3±1.42 a 22.7±1.31 a,b 20.3±1.18 b 48.4±2.72 c 43.1±2.14 d 38.3±2.27 e
Results are mean±SD for six rats. Values expressed: total cholesterol, HDL-cholesterol, and LDL-cholesterol, milligrams per deciliter. Values that
have a different letter (a, b, c, d, e, f) differ significantly with each other (P<0.05; Duncan's multiple range test)
Table 3 Effect of dietary chitosan supplementation on the levels of total cholesterol, lipid peroxides, and reduced glutathione (GSH) and the activities of
glutathione-dependent antioxidant enzymes [glutathione peroxidase (GPx) and glutathione reductase (GR)] in the heart tissue of young and aged rats













Total cholesterol 2.72±0.17 a,b 2.56±0.14 a 2.43±0.16 a 3.68±0.32 c 3.29±0.21 d 3.04±0.25 b,d
Lipid peroxides 1.08±0.07 a 0.98±0.06 a 0.97±0.07 a 2.58±0.14 b 1.96±0.09 c 1.54±0.11 d
GSH 10.9±0.84 a 12.3±1.02 a,b 14.5±1.17 c 7.54±0.61 d 8.76±0.69 d,e 9.52±0.85 a,e
GPx 5.23±0.35 a 5.51±0.41 a,b 5.98±0.37 b 3.12±0.18 c 4.05±0.26 d 4.56±0.34 d
GR 0.43±0.02 a 0.52±0.04 b 0.58±0.03 c 0.22±0.01 d 0.29±0.03 e 0.36±0.02 f
Results are mean±SD for six animals. Values expressed: total cholesterol, milligrams per gram wet tissue; lipid peroxides, nanomoles MDA
released per milligram protein; GSH, micrograms per milligram protein; GPx, micrograms GSH oxidized per minute per milligram protein; GR,
nanomoles NADPH oxidized per minute per milligram protein. Values that have a different letter (a, b, c, d, e, f) differ significantly with each other
(P<0.05; Duncan's multiple range test)
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studies by Xu et al. (2007) suggested that chitosan improve
lipid metabolism by regulating total cholesterol and LDL-
cholesterol by upregulation of hepatic LDL receptor mRNA
expression, increasing the excretion of fecal bile acids.
Previous studies (Yao and Chiang 2002) pointed out that
chitosan supplementation was capable of lowering the levels
of plasma total cholesterol and LDL-cholesterol in experimen-
tal animals. In the present study, a slight decline in the level of
total cholesterol and LDL-cholesterol were also noted in
Group Ic chitosan-fed young rats, ascertaining the anticholes-
terolemic property of chitosan (Ylitalo et al. 2002).
Sumiyoshi and Kimura (2006) suggested that the lipid-
lowering effects of chitosan might be mediated by increases
in fecal fat and/or bile acid excretion resulting from the binding
of bile acids, and by a decrease in the absorption of dietary
cholesterol from the small intestine. Studies by Maslowski et
al. (2009) have shown that normal intestinal microbiota might
also positively influence immune responses and protect against
the development of inflammatory diseases systemically
through the formation of short-chain fatty acids by fermenta-
tion of dietary fiber in the intestine. Chitosan, a biopolymer of
glucosamine derived from chitin that is chemically similar to
that of cellulose, acts as a dietary fiber in gastrointestinal tract
(Gallaher et al. 2000). It is possible that chitosan may function
through the generation of gut metabolites, such as short-chain
fatty acids/short-chain oligosaccharides, in attenuating the de-
velopment of inflammatory processes related to aging.
In the present study, there was a significant (P<0.05)
increase in the level of lipid peroxidation observed with a
concomitant reduction in the level of nonenzymatic (GSH)
and enzymatic (GPx and GR) antioxidants in the heart tissue
of Group IIa aged rats as compared to Group Ia young
control animals (Table 3). This concurs with the earlier
findings (Subramanian and James 2010), which indicated
that the higher vulnerability of aged myocardium to perox-
idative damage was mainly due to a decline in the level of
free radical scavengers. Depletion of GSH results in en-
hanced lipid peroxidation, and excessive lipid peroxidation
can cause increased GSH consumption during aging
(Denniss et al. 2011), as observed in the present study.
GSH protects the cardiac cell membranes from the damag-
ing action of lipid peroxide. The reduction in the activity of
GPx and GR may be due to the reduced availability of GSH.
GPx offers protection to the cellular and subcellular mem-
branes from the peroxidative damage by eliminating hydro-
gen peroxide and lipid peroxide (Li et al. 2005). Inhibition
of GSH-dependent antioxidant enzymes makes myocardial
cell membranes more susceptible to oxidative damage in
aging. GSH and GSH-dependent enzyme systems may be
directly related to the pathogenic mechanisms related to age-
associated disorders (Goncharova et al. 2007).
In our study, the dietary chitosan intake significantly atten-
uated the age-associated oxidative stress and maintained the
level of the glutathione-dependent antioxidant status in the
heart tissue at near normal. It probably did so by its antioxi-
dant nature. Reports by Jeon et al. (2003) have shown that
chitosan has strong antioxidative effects, which decrease free
radical production and increase antioxidant enzyme activities
during CCl4-induced lipid peroxidation in rats. Je et al. (2004)
have suggested that chitosan may eliminate various free rad-
icals by the action of nitrogen on the C-2 position of the
chitosan. Xie et al. (2001) reported that the scavenging mech-
anism of chitosan is related to the fact that the free radicals can
react with the hydrogen ion from the ammonium ions to form
a stable molecule. The normal young rats receiving chitosan
(Group Ic) did not show any significant change when com-
pared with normal (Group Ia) rats, indicating that it does not
per se have any adverse effects.
In conclusion, the overall antiaging effect of dietary chito-
san intake is probably related to its ability to inhibit the
increased accumulation of lipids both in the systemic circula-
tion and in the myocardium by its antilipidemic property, or to
normal maintenance of the activities of glutathione-dependent
antioxidant enzymes and the level of GSH, which protect
myocardial membrane against oxidative stress by decreasing
lipid peroxidation reactions.
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